For the quarter ending 2025-09-30, RKDA had -$256K decrease in cash & cash equivalents over the period. -$257K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 856 | -1,859 |
| Change in fair value of common stock warrant and option liabilities | 561 | 1,314 |
| Change in fair value of contingent consideration | 0 | -2,000 |
| Depreciation | 2 | 28 |
| Lease amortization | 5 | 117 |
| Amortization of note receivable discount | 0 | -69 |
| Gain on receipt of above food ingredients, inc. common stock | - | 1,067 |
| Gain on disposal of property and equipment | 0 | 0 |
| Gain on sale of rs durum wheat trait | 0 | 750 |
| Gain on receipt of above food ingredients, inc. common stock | 1,067 | - |
| Unrealized gain subsequent to receipt of above food ingredients, inc. common stock | 1,698 | - |
| Stock-based compensation | 53 | 164 |
| Credit loss | 256 | 4,489 |
| Write-down of inventories | 0 | - |
| Impairment of property and equipment | 0 | 0 |
| Accounts receivable and other receivables | -176 | 417 |
| Inventories | -33 | 585 |
| Prepaid expenses and other current assets | -173 | -544 |
| Other noncurrent assets | 0 | 56 |
| Accounts payable and accrued expenses | 458 | -630 |
| Amounts due to related parties | 0 | -30 |
| Other current liabilities | 0 | -57 |
| Operating lease liabilities | -10 | -129 |
| Net cash used in operating activities | -257 | -3,621 |
| Proceeds from sale of intangible assets | 0 | 750 |
| Proceeds from sale of property and equipment | 0 | 0 |
| Proceeds from sale of investments | 0 | 0 |
| Proceeds from sale of rs durum wheat trait | 0 | 0 |
| Cash paid related to sale of goodwheat | 0 | 0 |
| Purchases of property and equipment | 0 | 0 |
| Net cash provided by investing activities | 0 | 750 |
| Proceeds from espp purchases | 1 | 5 |
| Net cash provided by financing activities | 1 | 5 |
| Net decrease in cash and cash equivalents | -256 | -2,866 |
| Cash and cash equivalents at beginning of period | 4,242 | - |
| Cash and cash equivalents at end of period | 1,120 | - |
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)